Search

The biocompatible thiol-functionalized rGOSH/PMASH microcapsules encapsulating nerve growth factor (NGF) are arrayed onto a transparent and conductive substrate, i.e., indium tin oxide (ITO), to integrate electrically stimulated cellular differentiation, electrically controlled NGF release, and topographically rough nano-surfaces into a 3-D platform for nerve regeneration. The rGOSH/PMASH microcapsules with microscale topography function not only as an adhesive coating to promote the adhesion of PC12 cells but also as electroactive NGF-releasing electrodes that stimulate NGF release and accelerate the differentiation of PC12 cells during electrical stimulation. Once electrical treatment is applied, NGF release and electrically enhanced cellular differentiation lead to an obvious increase both in the percentage of cells with neurites and in the neurite length. This length can reach nearly 90 μm within 2 days of cell culture. The average neurite length is significantly increased (four-fold) after culture on the rGOSH/PMASH microcapsule substrate for 2 days compared with culture on a substrate without an rGOSH/PMASH coating. These multifunctional rGOSH/PMASH microcapsules may be used as potential 3-D patterned substrates for neural regeneration and neural prosthetics in tissue engineering applications. [ABSTRACT FROM AUTHOR]

A novel photo-responsive drug carrier that doubles as a photothermal agent with a nanocookie-like structure is constructed by coating amorphous carbon on a mesoporous silica support self-assembled on a sheet of reduced graphene oxide. With a large payload (0.88 mmolg−1) of a hydrophobic anticancer drug, (S)-(+)-camptothecin (CPT), nanocookies simultaneously provide a burst-like drug release and intense heat upon near-infrared exposure. Being biocompatible yet with a high efficiency for cell uptake, nanocookies have successfully eradicated subcutaneous tumors in 14 days following a single 5 min NIR irradiation without distal damage. These results demonstrate that the nanocookie is an excellent new delivery platform for local, on-demand, NIR-responsive, combined chemotherapy/hyperthermia for tumor treatment and other biomedical applications. [ABSTRACT FROM AUTHOR]